LKFT CIK: 1421876

Lakefront Biotherapeutics NV

  • Belgium
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions EUR
FY21:
4.86
FY22:
4.24
FY23:
3.86
FY24:
3.34
FY25:
3.08
(positive)
Change from FY21 to FY25
billions EUR
FY21:
0.33
FY22:
0.50
FY23:
0.50
FY24:
0.80
FY25:
0.33
Total assets
Change from FY21 to FY25
billions EUR
FY21:
5.19
FY22:
4.73
FY23:
4.36
FY24:
4.14
FY25:
3.41

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions EUR
FY21:
0.57
FY22:
0.52
FY23:
0.43
FY24:
0.34
FY25:
0.15
(negative)
Change from FY21 to FY25
billions EUR
FY21:
1.98
FY22:
1.69
FY23:
1.13
FY24:
0.90
FY25:
0.02
(positive)
Change from FY21 to FY25
billions EUR
FY21:
2.64
FY22:
2.53
FY23:
2.80
FY24:
2.90
FY25:
3.24
Total liabilities & equity
Change from FY21 to FY25
billions EUR
FY21:
5.19
FY22:
4.73
FY23:
4.36
FY24:
4.14
FY25:
3.41

All amounts in billions EUR Data source:SEC EDGAR